Latest News & Features
Americas
Gilead Sciences, a biopharmaceutical company based in the US, has entered into a licensing and collaboration agreement with South Korean healthcare company Yuhan. 10 January 2019
Biotechnology
US-based Locus Biosciences has announced it will license its CRISPR-Cas3 technology to Janssen, a subsidiary of American pharmaceutical company Johnson & Johnson, in a deal worth a potential $818 million. 9 January 2019
Americas
Los Angeles-based law firm Pierce Bainbridge Beck Price & Hecht has hired two partners to its New York office. 9 January 2019
Big Pharma
The UK government has published further guidance on the regulation of medicines, medical devices and clinical trials in the event of a no-deal Brexit. 8 January 2019
Asia
The Supreme Court of India has ruled that biotechnology company Monsanto’s patent for genetically modified cotton seeds is valid and enforceable in the country. 8 January 2019
Americas
American pharmaceutical firm Eli Lilly and Company has announced a deal to acquire Loxo Oncology in a $8 billion deal. 7 January 2019
Big Pharma
India’s Department of Pharmaceuticals has removed a price cap from a range of essential patented drugs used in the treatment of rare diseases. 7 January 2019
Big Pharma
Teva Pharmaceuticals has announced that it has resolved a dispute with Amgen over Teva’s generic cinacalcet HCI product. 4 January 2019
Americas
American pharmaceutical company Bristol-Myers Squibb has announced it is purchasing drug manufacturer Celgene in a $74 billion deal. 3 January 2019
Americas
Nuvo Pharmaceuticals has acquired the rights covering more than 20 drugs from fellow Canadian company Aralez Pharmaceuticals. 2 January 2019